Literature DB >> 20692731

Current management of biliary complications after liver transplantation: emphasis on endoscopic therapy.

Domingo Balderramo1, Miguel Navasa, Andres Cardenas.   

Abstract

Biliary complications occur in 5-25% of patients after liver transplantation and represent a major source of morbidity in this group of individuals. The major risk factor for most of these complications is ischemia of the bile tree usually due to obstruction or vascular insufficiency of the hepatic artery. The most common complications include biliary strictures (anastomostic and nonanastomotic), bile leaks, and biliary filling defects. The initial diagnostic approach starts with a high index of suspicion along with an abdominal ultrasound and Doppler exam. Magnetic resonance imaging is highly sensitive and is usually reserved for confirmation. The vast majority of these complications can be successfully treated with endoscopic retrograde cholangiography, however if this procedure cannot be performed a percutaneous approach or surgery is recommended. Nonanastomotic strictures and living donor recipients present a less favorable response to endoscopic management. This review focuses on the current diagnostic and therapeutic approaches for the management of biliary complications after liver transplantation.
Copyright © 2010 Elsevier España, S.L. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20692731     DOI: 10.1016/j.gastrohep.2010.05.008

Source DB:  PubMed          Journal:  Gastroenterol Hepatol        ISSN: 0210-5705            Impact factor:   2.102


  15 in total

1.  A "reappearance" of gallbladder in a liver transplant recipient.

Authors:  Al Warith Al Hashmi; Fabrizio Panaro; Francis Navarro
Journal:  Hepatobiliary Surg Nutr       Date:  2018-10       Impact factor: 7.293

2.  Successful treatment of complex cholangiolithiasis following orthotopic liver transplantation with interventional radiology.

Authors:  Chuan-Guo Zhou; Bao-Jie Wei; Kun Gao; Ding-Ke Dai; Ren-You Zhai
Journal:  World J Gastroenterol       Date:  2015-02-14       Impact factor: 5.742

Review 3.  Advances in endoscopic management of biliary complications after living donor liver transplantation: Comprehensive review of the literature.

Authors:  Milljae Shin; Jae-Won Joh
Journal:  World J Gastroenterol       Date:  2016-07-21       Impact factor: 5.742

Review 4.  Endoscopic Management of Anastomotic Strictures after Liver Transplantation.

Authors:  Dong Wook Lee; Hyeong Ho Jo; Juveria Abdullah; Michel Kahaleh
Journal:  Clin Endosc       Date:  2016-09-30

Review 5.  An Update on Endoscopic Management of Post-Liver Transplant Biliary Complications.

Authors:  Hyun Woo Lee; Najmul Hassan Shah; Sung Koo Lee
Journal:  Clin Endosc       Date:  2017-04-17

6.  Endoscopic therapy for biliary strictures complicating living donor liver transplantation: Factors predicting better outcome.

Authors:  Harshavardhan B Rao; Hasim Ahamed; Suprabha Panicker; Surendran Sudhindran; Rama P Venu
Journal:  World J Gastrointest Pathophysiol       Date:  2017-05-15

Review 7.  Biliary strictures complicating living donor liver transplantation: Problems, novel insights and solutions.

Authors:  Harshavardhan B Rao; Arjun Prakash; Surendran Sudhindran; Rama P Venu
Journal:  World J Gastroenterol       Date:  2018-05-21       Impact factor: 5.742

Review 8.  Endoscopic management of anastomotic stricture after living-donor liver transplantation.

Authors:  Dong Wook Lee; Jimin Han
Journal:  Korean J Intern Med       Date:  2019-02-25       Impact factor: 2.884

Review 9.  Post-liver transplant biliary complications: Current knowledge and therapeutic advances.

Authors:  Irina Boeva; Petko Ivanov Karagyozov; Ivan Tishkov
Journal:  World J Hepatol       Date:  2021-01-27

10.  Efficacy of rabbit anti-thymocyte globulin for steroid-resistant acute rejection after liver transplantation.

Authors:  Jae Geun Lee; Juhan Lee; Jung Jun Lee; Seung Hwan Song; Man Ki Ju; Gi Hong Choi; Myoung Soo Kim; Jin Sub Choi; Soon Il Kim; Dong Jin Joo
Journal:  Medicine (Baltimore)       Date:  2016-06       Impact factor: 1.889

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.